Condition: Multiple Myeloma · Sponsor: The First Affiliated Hospital with Nanjing Medical University
The purpose of this study is to evaluate the efficacy and safety of SVRd in NDMM patients presenting with extramedullary disease.
This description comes directly from the study's public registry record.
Yuanyuan Jin, Doctor · 025-83714511 · 827508088@qq.com
Lijuan Chen, Doctor · 025-83714511 · chenljb@126.com
Always discuss trial participation with your own doctor first.
| Changzhou Second People's Hospital | Changzhou, Jiangsu, China | Not Yet Recruiting |
| Nanjing First People's Hospital | Nanjing, Jiangsu, China | Not Yet Recruiting |
| The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| Affiliated Hospital of Nantong University | Nantong, Jiangsu, China | Not Yet Recruiting |
| Taizhou People's Hospital | Taizhou, Jiangsu, China | Not Yet Recruiting |
| Yancheng First People's Hospital | Yancheng, Jiangsu, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05900882